$GNPX News Article - Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of REQORSA(TM) Immunogene Therapy in Combination with Tagrisso to Treat Non-Small Cell Lung Cancer
https://marketwirenews.com/news-releases/genp...99471.html